Deletion and point mutations of PTHLH cause brachydactyly type E.

Institut für Medizinische Genetik, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany.
The American Journal of Human Genetics (Impact Factor: 11.2). 02/2010; 86(3):434-9. DOI: 10.1016/j.ajhg.2010.01.023
Source: PubMed

ABSTRACT Autosomal-dominant brachydactyly type E (BDE) is a congenital limb malformation characterized by small hands and feet predominantly as a result of shortened metacarpals and metatarsals. In a large pedigree with BDE, short stature, and learning disabilities, we detected a microdeletion of approximately 900 kb encompassing PTHLH, the gene coding for parathyroid hormone related protein (PTHRP). PTHRP is known to regulate the balance between chondrocyte proliferation and the onset of hypertrophic differentiation during endochondral bone development. Inactivation of Pthrp in mice results in short-limbed dwarfism because of premature differentiation of chondrocyte. On the basis of our initial finding, we tested further individuals with BDE and short stature for mutations in PTHLH. We identified two missense (L44P and L60P), a nonstop (X178WextX( *)54), and a nonsense (K120X) mutation. The missense mutation L60P was tested in chicken micromass culture with the replication-competent avian sarcoma leukosis virus retroviral expression system and was shown to result in a loss of function. Thus, loss-of-function mutations in PTHLH cause BDE with short stature.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Diabetes is one of the fastest growing diseases worldwide, with an immense economic and health burden attached. It is now well accepted that a deficiency of functional insulin-producing pancreatic beta-cells is the main cause for all forms of diabetes. Several approaches are being taken to increase functional beta-cell mass. These include differentiation of new beta-cells from stem cells or progenitor cells, transdifferentiation of beta-cells from other mature cell types, as well as finding ways to enhance the function, proliferation, survival, and regeneration of preexisting beta-cells. This article enumerates on the role of parathyroid hormone-related protein (PTHrP) and its mode of action on pancreatic beta-cell function, prolifera-tion, and survival in rodents as well as in human beta-cells. A further understanding of the mechanism of action of PTHrP and its role in the normal physiology and patho-physiology of the beta-cell will be important for its potential use in future as a therapeutic treatment for diabetes. Diabetes Diabetes is one of the fastest growing diseases worldwide, with a steep rise in its incidence expected in the next few decades [1, 2]. In the last two decades, among US adults aged 18 years or older, the annual number of new cases as well as diagnosed diabetes incidence almost tripled [3]. The estimated economic toll of diabetes is increasing nationally and internationally [4]. There is an urgent need to find ways to treat and/or cure diabetes, to alleviate the health and economic burden placed by this disease. Diabetes mellitus is a metabolic disease of insulin insufficiency leading to high blood sugar levels. There are many forms of diabetes, of which the two major types are type 1 diabetes (T1D) and type 2 diabetes (T2D). T1D is an autoimmune disease in which the body's immune system specifically attacks and destroys the pancreatic beta-cell, causing severe insulin deficiency and hyperglycemia [5, 6]. T2D, the more prevalent form of the disease, results from a combination of insulin resistance, inability of the body to properly sense and respond to insulin, and insufficient insulin production [7, 8]. It is now well accepted that all forms of diabetes ultimately develop due to an inadequate insulin supply, leading to increased blood glucose levels. If left untreated, chronic hyperglycemia causes tissue dam-age, producing the secondary complications of diabetes, which include diabetic neuropathy, nephropathy, retinop-athy, cardiovascular disease, and eventually increased mortality [3].
    Clinical Reviews in Bone and Mineral Metabolism 06/2014;
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Interstitial deletions of chromosome 12p are rare, and the phenotype spectrum is therefore still unknown. The thirteen patients reported so far suffer from developmental delay, optic nerve hypoplasia, micropenis, hypoplastic hair and skin, oligodontia, brachydactyly, and arterial hypertension. We report a de novo 12p12.2–p11.22 deletion of 9.2 Mb detected by array CGH analysis in a boy with global developmental delay, muscular hypotonia, postnatal microcephaly, facial dysmorphism including small ears, epicanthus, broad nasal bridge and hypoplastic nostrils. In addition, the patient had optic nerve atrophy, inverted nipples, micropenis, and a hemangioma. The deleted region encompasses more than 40 reference genes. We compare phenotype and deletion extent of our index patient to that of previous reports and thereby contribute to the understanding of interstitial 12p deletion phenotypes. Knowledge of the pattern of this deletion phenotype will help clinicians to diagnose this abnormality in their patients and to counsel the parents accordingly. Further descriptions may be able to contribute to the clarification.
    Meta Gene. 12/2014; 2:72–82.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Parathyroid hormone-like hormone (PTHLH, MIM 168470) is a humoral factor, structurally and functionally related to parathyroid hormone, which mediates multiple effects on chondrocyte, osteoblast and osteoclast function. Mutations and copy number imbalances of the PTHLH locus and in the gene encoding its receptor, PTHR1, result in a variety of skeletal dysplasias including brachydactyly type E, Eiken syndrome, Jansen metaphyseal chondrodysplasia and Blomstrand type chondrodysplasia. Here we describe three individuals with duplications of the PTHLH locus, including two who are mosaic for these imbalances, leading to a hitherto unrecognized syndrome characterized by acro-osteolysis, cortical irregularity of long bones and metadiaphyseal enchondromata.Journal of Human Genetics advance online publication, 10 July 2014; doi:10.1038/jhg.2014.58.
    Journal of Human Genetics 07/2014; · 2.53 Impact Factor

Full-text (2 Sources)

Available from
May 17, 2014